AMG 900
Catalog No. A11066
AMG 900是一种新型有效且高度选择性的泛Aurora激酶抑制剂,在紫杉烷抗性肿瘤细胞系中具有活性。
- Tomoya Takeda, .et al. AT9283 exhibits antiproliferative effect on tyrosine kinase inhibitor-sensitive and -resistant chronic myeloid leukemia cells by inhibition of Aurora A and Aurora B, Oncol Rep, 2020, August 18
Catalog Num | A11066 |
---|---|
M. Wt | 503.6 |
Formula | C28H21N7OS |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 945595-80-2 |
Synonyms | AMG-900, AMG900 |
SMILES | CC1=CSC(=C1)C2=NN=C(C3=CC=CC=C32)NC4=CC=C(C=C4)OC5=C(C=CC=N5)C6=NC(=NC=C6)N |
AMG 900是一种新型有效且高度选择性的泛Aurora激酶抑制剂,在紫杉烷抗性肿瘤细胞系中具有活性。
Targets
Target | Value |
---|---|
AuroraC | IC50: 1nM |
AuroraB | IC50: 4nM |
AuroraA | IC50: 5nM |
p38α | IC50: 53nM |
TYK2 | IC50: 220nM |
JNK2 | IC50: 520nM |
Met | IC50: 550nM |
Tie-2 | IC50: 650nM |
In vitro (25°C) | DMSO | 90 mg/mL (178.71 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 1% DMSO+30% polyethylene glycol+1% Tween 80 | 19 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 19.86 mL | 99.29 mL | 198.57 mL |
0.5 mM | 3.97 mL | 19.86 mL | 39.71 mL |
1 mM | 1.99 mL | 9.93 mL | 19.86 mL |
5 mM | 0.4 mL | 1.99 mL | 3.97 mL |
*The above data is based on the productmolecular weight 503.6. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.